دانلود کتاب دارو درمانی سیروز کبدی و عوارض آن

Liver cirrhosis, end stage of chronic liver diseases, is one of the leading causes of death worldwide, primarily due to its secondary severe complications, including ascites, acute variceal bleeding, portal vein thrombosis, hepatic encephalopathy, and liver and renal failure. Currently, liver transplantation remains the sole curative treatment option for liver cirrhosis. Besides, the efficacy and safety of “new” drugs for the prevention and treatment of liver cirrhosis related complications have been widely explored, and meanwhile, the indications of “old” drugs are further con­firmed and even expanded. Undoubtedly, such advances are potentially effective for the improvement of patients’ outcomes. For this reason, Prof. Yongping Yang and I decided to launch this book project to summarize the current status regarding phar­macotherapy for liver cirrhosis and its complications. Finally, a panel of famous experts, who are very skilled at the management of liver cirrhosis and have pub­lished high-impact papers related to this topic, have been invited to write a total of 14 chapters regarding etiological treatment of hepatitis B and C infection and cho­lestasis related liver cirrhosis, prevention and treatment of major liver cirrhosis related complications, and some promising drugs for the improvement of survival of patients with liver cirrhosis.